RxDoctor Payments Data

Andrew Peterson, DO

Internal Medicine · Biloxi, MSNPI 1306826854

Payments from drug & device makers

$2,677in general payments, 2019–2025

Across 170 payments — averaging $15.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$296
  • Bayer$203
  • AbbVie$176
  • Amgen$166
  • Otsuka America Pharmaceutical, Inc.$160
  • AstraZeneca$153
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$2,59297%
  • Education$853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,677 in reported general payments places this provider in the 75th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$290,881
Medicare patients
326
Services billed
22,666

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin158$162,476
OzempicSemaglutide83$103,951
EliquisApixaban65$76,033
MounjaroTirzepatide58$73,159
BiktarvyBictegrav/Emtricit/Tenofov Ala12$47,775
LinzessLinaclotide56$47,468
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$41,278
XareltoRivaroxaban29$34,566
Breztri AerosphereBudesonide/Glycopyr/Formoterol43$32,176
JanuviaSitagliptin Phosphate36$31,233
GemtesaVibegron17$23,514
Tresiba Flextouch U-100Insulin Degludec33$23,254
NexlizetBempedoic Acid/Ezetimibe21$20,951
TrulicityDulaglutide18$18,962
ZenpepLipase/Protease/Amylase12$18,494

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$18$162,476158 claims
Novo NordiskOzempic$94$103,95183 claims
Lilly USA, LLCMounjaro, Trulicity$45$92,12176 claims
PfizerEliquis$296$76,03365 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Shingrix$90$67,405122 claims
AbbVieLinzess, Synthroid$176$49,962112 claims
GileadBiktarvy$35$47,77512 claims
AstraZenecaBreztri Aerosphere, Symbicort$153$36,30457 claims
Johnson & JohnsonXarelto$44$34,56629 claims
MerckJanuvia$136$31,23336 claims
Sumitomo Pharma America, Inc.Gemtesa$19$23,51417 claims
Esperion Therapeutics, Inc.Nexlizet$14$20,95121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 846 internal medicine providers in Mississippi.

Other internal medicine in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →